VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $132 | -99.8% | 14 | -99.4% | 0.00% | -100.0% |
| Q2 2023 | $63,630 | 0.0% | 2,514 | 0.0% | 0.02% | 0.0% |
| Q1 2023 | $63,630 | +0.0% | 2,514 | 0.0% | 0.02% | 0.0% |
| Q4 2022 | $63,629 | +17.8% | 2,514 | 0.0% | 0.02% | +7.1% |
| Q3 2022 | $54,000 | – | 2,514 | +16660.0% | 0.01% | – |
| Q2 2022 | $0 | -100.0% | 15 | -99.3% | 0.00% | -100.0% |
| Q1 2022 | $51,000 | -39.3% | 2,015 | 0.0% | 0.01% | -40.0% |
| Q4 2021 | $84,000 | +250.0% | 2,015 | +303.0% | 0.02% | +233.3% |
| Q2 2021 | $24,000 | -7.7% | 500 | 0.0% | 0.01% | -25.0% |
| Q1 2021 | $26,000 | – | 500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |